Author: Vitaliy Dadalyan
-
Can Novavax’s Surge Continue Following Positive Data for Flu Vaccine?
If you think the broader market’s extreme pendulum swings are the definition of volatility, you should have a conversation with long-term investors of vaccine specialist Novavax (NVAX). To quickly recap the last 24 months: In 2018,…
-
Moody’s Lowers 3M’s Outlook to Negative From Stable Amid Rising Leverage Risk
Rating agency Moody’s Investors Service changed 3M Company’s (MMM) outlook to negative from stable due to expectations of higher leverage needs and weaker earnings for this year.Moody’s reaffirmed 3M’s A1 senior unsecured debt rating. The rating agency…
-
Occidental to cut pay of staff and executives: WSJ
According to the Wall Street Journal, Occidental Petroleum Corporation is set to cut the salaries of all U.S. employees by up to 30%. Yahoo Finance’s On The Move panel discuss the details….
-
Target CEO withdraws forecast, curbs spending
Amid the coronavirus outbreak, Target has been forced to scale back the remodeling of new store openings as people stay home. Yahoo Finance’s On The Move panel breaks down the details….
-
Facebook Looks Compelling at Current Levels, Says 5-Star analyst
The coronavirus hasn’t spared the mega-caps, and social media giant Facebook is a case in point. Among its FAANG peers, year-to-date, Facebook (FB) has suffered the most, shedding 24% of its value. Should the sharp pullback…
-
Unemployment claims are skyrocketing across the U.S.
Initial jobless claims data for last week is expected to skyrocket as the U.S. economy feels the pain of the COVID-19 pandemic….
-
EU says Johnson & Johnson's deal for Takeda patch may harm competition
EU antitrust regulators have opened a full investigation into Johnson & Johnson’s acquisition of Takeda Pharmaceutical’s surgical patch product TachoSil, concerned that the deal could lead to reduced choice and higher prices for customers. Takeda, Japan’s…
-
EKA Solutions Offer Remote Business Service for Brokers
EKA Solutions will now offer its Omni-TMS platform to brokers who are operating their business partly or entirely remotely due to the COVID-19 outbreak. …
-
Bill Ackman Puts Part of His Personal Fortune in Covid-19 Testing
(Bloomberg) — Bill Ackman said he has invested a portion of his personal wealth to help manufacture antibody testing kits produced by Covaxx, a newly formed subsidiary of closely-held United Biomedical Inc., amid the outbreak of…
-
Bernanke On How Coronavirus Differs From The 2008 Economic Crisis
The 2008 financial crisis was the result of the collapse of the financial system but the coronavirus could have the opposite impact of trickling its way towards the financial system, according to former Fed Chairman Ben…